Lloyd Price

JANUARY 20, 2025

They can directly engage with consumers while providing data and insights to healthcare providers to support patient-centered care. Email lloyd@nelsonadvisors.co.uk Nelson Advisors Healthcare Technology Newsletter > Mergers, Acquisitions, Growth, Strategy, Insights & Predictions. Subscribe Today!

Mental health 62

Mental health healthcare technology Telehealth Digital Health 62

Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Lloyd Price

SEPTEMBER 16, 2024

Exec Summary: The Morgan Stanley 22nd Annual Global Healthcare Conference was held in September 2024. Artificial Intelligence (AI) and Machine Learning (ML): AI and ML are revolutionising the healthcare industry, from drug discovery to patient diagnosis and treatment.

Digital Health 67

Digital Health Drug Development healthcare technology Leadership 67

Lloyd Price

NOVEMBER 21, 2023

By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. Palantir's products are used by a variety of industries, including healthcare.

Drug Development 73

Drug Development Health science healthcare technology Leadership 73

Lloyd Price

DECEMBER 2, 2024

By embracing technological advancements, focusing on personalised medicine, and addressing the challenges of chronic wounds, the industry can improve patient outcomes, reduce costs, and enhance the overall quality of care. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Digital Health 57

Digital Health healthcare technology Telemedicine Leadership 57

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. link] Healthcare Technology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

healthcare technology 76

healthcare technology Drug Development Leadership Digital Health 76

Lloyd Price

MAY 6, 2024

Exec Summary: AI has revolutionised the weather industry by providing faster, more accurate, and personalised weather predictions. This has significant benefits for public safety, disaster preparedness, and various industries that rely on weather information. Visit www.nelsonadvisors.co.uk Subscribe Today!

healthcare technology 73

healthcare technology Leadership Drug Development Digital Health 73

Lloyd Price

MAY 30, 2024

However, these early successes provide a promising outlook for the role and its potential to revolutionise healthcare with the responsible use of AI. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Leadership 76

Leadership healthcare technology Interoperability Drug Development 76

Healthcare IT Today

NOVEMBER 14, 2022

Brad Whitmore is a successful investor who has targeted a broad range of investments across various industries with an emphasis on businesses with long-term, sustainable competitive advantages and unique offerings relative to competitors. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

Life Science 96

Life Science HIPAA Drug Development healthcare technology 96

Lloyd Price

FEBRUARY 18, 2024

Mergers and acquisitions: The promising future of GLP-1s led to several mergers and acquisitions within the healthtech industry. These deals aimed to consolidate market share, expand research capabilities, and accelerate product development, further stimulating investor interest.

Pharmaceuticals 62

Pharmaceuticals healthcare technology Leadership Drug Development 62

Lloyd Price

AUGUST 7, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Interoperability 62

Interoperability Leadership EHR Drug Development 62

Lloyd Price

SEPTEMBER 6, 2024

Exec Summary: Co-pilots, AI-powered tools designed to assist humans in various tasks, are poised to revolutionise the healthcare industry. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Leadership 78

Leadership Drug Development healthcare technology Digital Health 78

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

SEPTEMBER 29, 2024

Market share: Market share is a measure of a company's dominance in its industry. Companies that operate in industries with a favourable regulatory environment are typically valued at a premium to those that operate in industries with a more challenging regulatory environment.

Leadership 67

Leadership Drug Development healthcare technology Digital Health 67

Lloyd Price

FEBRUARY 2, 2024

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times. Regulatory frameworks and industry-wide collaboration are key drivers.

Health Data 67

Health Data Interoperability healthcare technology Leadership 67

Lloyd Price

JULY 15, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Digital Health 62

Digital Health Mobile Health Telehealth Mental health 62

Healthcare IT News - Telehealth

MAY 6, 2020

In an age when nearly everyone is digitally connected in some way – even many senior citizens, who are often characterized as technophobic – it only makes sense that the healthcare industry is seeing a lot of connected health devices and remote patient monitoring (RPM) technologies. iRhythm Technologies.

Connected Health 216

Connected Health Telehealth Pharmaceuticals EHR 216

DrKumo Remote Patient Monitoring

FEBRUARY 29, 2024

The potential benefits of AI in healthcare discussed are influenced by various factors and may not apply universally. In today’s rapidly evolving world, technology continues to reshape various industries, and healthcare is no exception. What are the benefits of AI in drug development?

Mental health 40

Mental health Drug Development Health Data Patient Experience 40

Healthcare IT Today

DECEMBER 31, 2024

The industry is working to optimize information and data transfer between these groups, aiming to reduce redundancy and minimize manual processes that can introduce risks, whilst also generating process and product insights through technologies such as AI.

Interoperability 65

Interoperability Health IT Pharmaceuticals Digital Health 65

Healthcare IT Today

MAY 5, 2023

Whereas a traditional visit to the doctor can analyze one’s physical health in a fixed time, technology can gather data throughout a patient’s lived experiences, helping healthcare professionals understand patient backgrounds, experiences, and personal preferences on a deeper level. Tanja Dowe, CEO of Debiopharm Innovation Fund S.A.

Drug Development 111

Drug Development Primary Care Remote care Patient Experience 111